Announcements
- Publication of 2023 Annual Report & Notice of AGM
- Compelling Safety Profile of BVX001
- Innovate UK Grant Award to Accelerate ADC Pipeline
- BiVictriX – Full Year Results 2023
- Orphan Drug Designation & FDA INTERACT Meeting
- Grant of Options – PDMR/Director Dealings
- Holding(s) in Company
- BiVictriX Hosts Inaugural Roundtable Discussion
- Board Change
- Pipeline update on BVX002
More ▼
Key statistics
On Monday, BiVictriX Therapeutics PLC (BVX:LSE) closed at 13.00, -18.75% below its 52-week high of 16.00, set on Jul 25, 2023.
52-week range
Open | 13.00 |
---|---|
High | 13.00 |
Low | 13.00 |
Bid | 10.00 |
Offer | 14.00 |
Previous close | 13.00 |
Average volume | 2.72k |
---|---|
Shares outstanding | 82.53m |
Free float | 51.08m |
P/E (TTM) | -- |
Market cap | 10.73m GBP |
EPS (TTM) | -0.0351 GBP |
Data delayed at least 20 minutes, as of Jul 22 2024 09:54 BST.
More ▼